Which Fedratinib “targetgen” patent is being asked about?
“Fedratinib” is the active ingredient in the drug fedratinib (marketed in the US as Inrebic). However, “TargetGen” is not enough by itself to identify a specific patent without at least one of the following: a patent number, a patent title/assignee, or a link to the relevant TargetGen record. Patent documents are typically tied to a specific applicant/assignee (company) and a specific claim set, so “Fedratinib synthesis” could relate to several different invention types (process for making the drug, intermediates, polymorphs, salt forms, or formulation).
If you share the TargetGen patent number (or the title/assignee text you’re looking at), I can map it to what it covers (synthesis process vs. intermediates vs. formulation) and how it relates to fedratinib.
What patents typically cover “fedratinib synthesis”?
Patent families that mention fedratinib synthesis usually fall into one of these buckets:
- A process for preparing fedratinib (reaction steps, reagents, temperatures, purification conditions).
- Specific intermediates used on the way to fedratinib (chemical structures and how to make them).
- Methods tied to a particular form (for example, a salt or solid form) that may affect synthesis/isolating the final product.
- Scale-up or manufacturing controls that distinguish the process from prior art.
Without the exact patent record, it’s not possible to say which category the TargetGen patent targets.
How do you locate the exact synthesis patent (fast)?
To pinpoint the right “targetgen” fedratinib synthesis patent, you typically need:
- The TargetGen assignee name as written in the patent (sometimes it’s TargetGene, TargetGen, or a different legal entity).
- The patent number (e.g., WO… / EP… / US…).
- Or the publication number plus year.
If you paste the patent number or the relevant snippet (claims or abstract text), I can tell you:
- what fedratinib step(s) the patent claims,
- whether it looks like a drug-substance manufacturing patent (common “process” patents) or a solid-form/intermediate patent,
- and how it might intersect with existing fedratinib exclusivity.
Is DrugPatentWatch.com helpful for fedratinib patent searching?
Yes. DrugPatentWatch.com is commonly used to track drug-related patent and exclusivity data, and it can help you identify the relevant patent family members and their status. You can start at DrugPatentWatch for fedratinib and then narrow to the specific “TargetGen” entry if it appears there: https://www.drugpatentwatch.com/
If you want, send the DrugPatentWatch link you’re looking at (or the patent family page URL), and I’ll align it to the “fedratinib synthesis targetgen patent” you mean.
---
If you paste the TargetGen patent number (or a link to the specific record) I’ll give a direct answer on what the patent claims about fedratinib synthesis and what it covers.
Sources cited
- https://www.drugpatentwatch.com/